BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2015

Mar 5, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2015-03-03

Reporting Person: BAFFI ROBERT (EVP, Technical Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-03	Common Stock	A	10500	—	Acquired	109700	Direct
2015-03-05	Common Stock	M	11000	$17.86	Acquired	120700	Direct
2015-03-05	Common Stock	M	3051	$14.39	Acquired	123751	Direct
2015-03-05	Common Stock	S	14051	$116.3683	Disposed	109700	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-03-03	Stock Option (right to buy) Common Stock	$108.36	A	23900	Acquired	2025-03-02	Common Stock (23900)	Direct
2015-03-05	Stock Option (right to buy) Common Stock	$17.86	M	11000	Disposed	2018-12-16	Common Stock (11000)	Direct
2015-03-05	Stock Option (right to buy) Common Stock	$14.39	M	3051	Disposed	2019-05-11	Common Stock (3051)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	23935	Indirect

Footnotes

F1: Restricted stock units granted on March 3, 2015. Price not applicable.

F2: The price in column 4 is a weighted average price. The price actually received ranged from $116.30 to $116.44. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the amount of shares sold at each price within the range.

F3: Option grant vests 6/48ths on September 3, 2015, and 1/48th on the 3rd day of every month thereafter.

F4: Option grant vests 6/48ths on June 17, 2009 and 1/48th on the 17th of every month thereafter.

F5: Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.

F6: Option grant vests 6/48ths on November 11, 2009 and 1/48th on the 11th of every month thereafter.